Olema Oncology is targeting two markets worth $15 billion with the attitude, “we punch above our weight,” according to CEO Sean Bohen.
The post Olema Stock Has Soared 551% This Year. Its CEO Thinks It’s Still Undervalued. appeared first on Investor’s Business Daily.